Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Bioanalysis|March 29, 2012
Tissue sample preparation in bioanalytical assaysKerri M Smith, Yan Xu
Analytical Chemistry|December 8, 2020
Sensitive and Reproducible Mass Spectrometry-Compatible RP-UHPLC Analysis of Tricarboxylic Acid Cycle and Related Metabolites in Biological Fluids: Application to Human UrineKerri M Smith, Ian D Wilson, Paul D Rainville
Bioorganic & Medicinal Chemistry Letters|August 3, 2011
Design and synthesis of a biotinylated probe of COX-2 inhibitor nimesulide analog JCC76Bo Zhong, Rati Lama, Kerri M Smith, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 5, 2011
Determination of hexamethylene bisacetamide, an antineoplastic compound, in mouse and human plasma by LC-MS/MSKerri M Smith, Wannarasmi Ketchart, Xiang Zhou, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2012
Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276Krisztina M Papp-Wallace, Magdalena A Taracila, Kerri M Smith, et al.
Journal of Chromatography. A|April 18, 2022
Application of a hybrid zwitterionic hydrophilic interaction liquid chromatography column in metabolic profiling studiesArtemis Lioupi, Christina Virgiliou, Thomas H Walter, et al.
International Journal of Molecular Sciences|January 26, 2019
The Chemical Characterization of Eleutherococcus senticosus and Ci-wu-jia Tea using UHPLC-UV-QTOF/MSYan-Hong Wang, Yonghai Meng, Chunmei Zhai, et al.
Journal of Medicinal Chemistry|March 23, 2012
Identification of a class of novel tubulin inhibitorsXin Yi, Bo Zhong, Kerri M Smith, et al.
The Journal of Biological Chemistry|July 31, 2012
Exploring the role of a conserved class A residue in the Ω-Loop of KPC-2 β-lactamase: a mechanism for ceftazidime hydrolysisPeter S Levitt, Krisztina M Papp-Wallace, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2013
Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinationsSebastian G Kurz, Kerstin A Wolff, Saugata Hazra, et al.
Pageof 2